Primary Care

Sleep Medicine

Questions discussed in this category

How do you manage daytime somnolence without a clear cause?

E.g., negative sleep study, good sleep hygiene, no offending medications, no psychiatric disorder.

1 Answer available

What is your approach to helping parents manage sleep disturbances in patients with autism spectrum disorder?

1 Answer available

How do you monitor safety, effectiveness, and adherence to therapy when using sedative hypnotics in patients with insomnia?

Do you require patients to complete a controlled substance agreement or obtain routine interval urine drug screens?

1 Answer available

How do you sequence pharmacologic treatments for primary insomnia?

6 Answers available

Will you incorporate the use of tirzepatide in the management of patients with OSA?

The recently published SURMOUNT-OSA trial showed positive results

1 Answer available

How do you counsel patients with Parkinson's disease who are interested in starting GLP-1 agonists for neuroprotective benefits?

2 Answers available

How do you treat restless leg syndrome in patients with end-stage renal disease?

In light of 2025 guidelines for treatment for RLS and PLMD

1 Answer available

How do you manage persistent insomnia despite ASV titration in patients with complex sleep apnea?

1 Answer available

Do you grade severity of OSA by AHI or RDI?

5 Answers available

What is the best treatment for treatment resistant restless leg syndrome?

2 Answers available

What are preferred sleep aids in elderly patients with dementia?

6 Answers available

How do you counsel and manage patients who meet criteria for sleep apnea based on 3% but not 4% desaturation?

2 Answers available

Is there a role for nocturnal supplemental oxygen as opposed to no therapy in patients with OSA who are unable to tolerate PAP therapy?

1 Answer available

Do you start PAP in patients who have an overall AHI of less than 5 but demonstrate significant apneas/hypopneas in REM sleep?

3 Answers available

What is your approach to counseling and management of patients with severe symptomatic OSA whose PAP devices have been recalled?

1 Answer available

How are you navigating approval of CPAP for patients with a high suspicion for OSA on chronic oxygen who are unable to complete an in-lab PSG?

2 Answers available

How do you navigate PAP approval for patients with tracheobronchomalacia or excessive dynamic airway collapse who do not have OSA?

1 Answer available

What is your approach to the use of acetazolamide in patients with OSA?

1 Answer available

How do you define severe hypoxic burden on home sleep testing?

1 Answer available

Do you employ the use of noctournal oximetry to assess for a need for supplemental O2 in addition to auto PAP in patients with OSA who have not had an in lab CPAP titration study?

2 Answers available

What are your recommendations for screening for sleep disorders in patients with IDD?

Since these patients or their caregivers may not know the symptoms related to sleep disorders and the negative effects on their already compromised ne...

1 Answer available

Do you routinely recommend a sleep study in patients with clinical history of REM-sleep behavior disorder?

Does this add any value?

1 Answer available

Papers discussed in this category

Sleep Med Rev, 2021 Jun 10

REM sleep behavior disorder: Mimics and variants.

The Journal of physiology, 1998-08-01

The effect of rapid eye movement (REM) sleep on upper airway mechanics in normal human subjects.

The New England journal of medicine, 2024 Jun 21

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.

Nature medicine, 2018 Jun 11

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.

Medicine, 2016 May

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.

Neurology, 2012 Apr 25

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.

Lancet (London, England), 2017 Aug 03

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

The New England journal of medicine, 2024 Apr 04

Trial of Lixisenatide in Early Parkinson's Disease.

Ageing research reviews, 2023 Jun 14

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.

Related Topics in Primary Care